Social Security Clawbacks Hit a Million More People Than Agency Chief Told Congress
More than 2 million people a year have been sent notices that Social Security overpaid them and demanding they repay the money. That’s twice as many as the head of Social Security disclosed at a congressional hearing in October.
KFF Health News editor-at-large for public health Céline Gounder discusses how families of transgender youth are uprooting their lives due to anti-trans policies and their ripple effects.
Watch: Thinking Big in Public Health, Inspired by the End of Smallpox
A conversation about how the lessons from the victory over smallpox could be applied to public health challenges today.
Watch: In Emergencies, First Comes the Ambulance. Then Comes the Bill.
This installment of InvestigateTV and KFF Health News’ “Costly Care” series delves into the lack of cost protections for patients who find themselves on the hook for an emergency ground ambulance ride.
How the Texas Trial Changed the Story of Abortion Rights in America
Stark, plaintive testimony from women denied abortion care represents the start of “the 50-year fight to get rid of Dobbs,” one historian says.
Watch: Payback for the Opioid Crisis: How Did the Sackler Family Skirt Liability?
KFF Health News senior correspondent Aneri Pattani appeared on PBS NewsHour to discuss the ruling surrounding drugmaker Purdue Pharma’s role in the opioid crisis and her reporting into the ongoing distribution of opioid settlement funds.
Watch: 5th Circuit Judges Question Two-Decade-Old Approval of Abortion Pill
The 5th Circuit Court of Appeals in New Orleans heard oral arguments Wednesday in a case brought by conservative Christian abortion opponents seeking to revoke FDA approval of mifepristone, a medication used in more than half of abortions in the U.S.
After Idaho’s Strict Abortion Ban, OB-GYNs Stage a Quick Exodus
At least two Idaho hospitals are ending labor and delivery services, with one citing the state’s “legal and political climate” and noting that “recruiting replacements will be extraordinarily difficult” as doctors leave.
Watch: Rulings on Abortion Pill Have Far-Reaching Repercussions
Sarah Varney, a senior correspondent for KHN, joins Ali Rogin of PBS NewsHour to discuss the ruling by a federal judge in Texas that threatens nationwide access to the widely used abortion drug mifepristone, and a separate ruling in Washington state that reached the opposite conclusion.
Sen. Sanders Shows Fire, but Seeks Modest Goals, in His Debut Drug Hearing as Health Chair
The Vermont independent and former presidential candidate was all fire and brimstone at his first hearing on drug prices as head of the Senate HELP Committee. He also pursued a more modest goal of covid vaccine price reductions. It isn’t clear whether Sanders will succeed in even that, but he has put affordability front and center.
Judge Signals He Could Rule to Halt Sales of Common Abortion Pill
A U.S. District Court case is being widely followed because the judge’s decision could overturn the FDA’s approval of mifepristone two decades ago. With abortion rights polling well even in red states, anti-abortion activists are increasingly turning to the courts to achieve their aims.
Girls in Texas Could Get Birth Control at Federal Clinics, Until a Christian Father Objected
A Donald Trump-appointed federal judge agreed that even the possibility that the father’s daughters might access contraception without his permission violated the tenants of his Christian faith.
Watch: Emergency Room Turns Simple Injury Into a Big Bill
This installment of InvestigateTV and KHN’s “Costly Care” series looks at the case of a New Orleans woman whose thumb injury saddled her with a big ER bill for a tetanus shot and some minor care.
Watch: Walgreens Won’t Sell Abortion Pill in 21 States Under GOP Threat of Legal Action
Under pressure from Republican attorneys general, the nation’s second-largest pharmacy chain says it will not dispense the abortion pill mifepristone.
One Texas Judge Will Decide Fate of Abortion Pill Used by Millions of American Women
“What happens in Texas doesn’t stay in Texas,” warns an abortion rights advocate bracing for a district judge’s ruling on whether the abortion pill mifepristone was properly authorized by the FDA. His decision could force the medication off the U.S. market.
Watch: In Insurers’ Eyes, Not All Midwives Are Equal
The first installment of InvestigateTV and KHN’s “Costly Care” series explores one California mother’s experience struggling to get reimbursed for midwifery care and the differences between providers that may determine whether insurance covers them.
